$153 Million is the total value of Healthcare Value Capital, LLC's 45 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 91.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $18,701,000 | +102.5% | 100,000 | +100.0% | 12.23% | +80.5% |
| MDY | Sell | SPDR S&P MIDCAP 400 ETF TRput | $12,529,000 | -26.7% | 50,000 | -28.6% | 8.20% | -34.7% |
| TWM | New | PROSHARES TRcall | $11,468,000 | – | 250,000 | +100.0% | 7.50% | – |
| AMRI | New | ALBANY MOLECULAR RESH INC | $8,332,000 | – | 448,200 | +100.0% | 5.45% | – |
| AUXL | New | AUXILIUM PHARMACEUTICALS INCcall | $8,154,000 | – | 300,000 | +100.0% | 5.33% | – |
| WCG | New | WELLCARE HEALTH PLANS INCput | $7,940,000 | – | 125,000 | +100.0% | 5.19% | – |
| BAX | New | BAXTER INTL INCcall | $7,358,000 | – | 100,000 | +100.0% | 4.81% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $6,869,000 | +211.7% | 130,000 | +136.4% | 4.49% | +177.9% |
| IWM | ISHARESput | $5,817,000 | +0.8% | 50,000 | 0.0% | 3.80% | -10.1% | |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $4,878,000 | -29.7% | 179,481 | -46.3% | 3.19% | -37.3% |
| DGX | QUEST DIAGNOSTICS INC | $4,472,000 | +8.2% | 77,208 | 0.0% | 2.93% | -3.5% | |
| MRK | MERCK & CO INC NEW | $4,371,000 | +13.4% | 77,000 | 0.0% | 2.86% | +1.1% | |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $4,187,000 | -57.0% | 133,558 | -72.5% | 2.74% | -61.7% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDcall | $3,963,000 | -50.6% | 75,000 | -62.5% | 2.59% | -55.9% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $3,714,000 | -23.9% | 57,239 | -30.4% | 2.43% | -32.2% |
| QLTI | Buy | QLT INC | $3,484,000 | +18.8% | 626,639 | +19.0% | 2.28% | +5.9% |
| HNT | HEALTH NET INC | $3,401,000 | +14.6% | 100,000 | 0.0% | 2.22% | +2.2% | |
| HNT | Buy | HEALTH NET INCcall | $3,401,000 | +129.2% | 100,000 | +100.0% | 2.22% | +104.3% |
| PFE | New | PFIZER INC | $3,212,000 | – | 100,000 | +100.0% | 2.10% | – |
| SNY | Buy | SANOFIsponsored adr | $3,018,000 | +71.9% | 57,735 | +76.4% | 1.97% | +53.1% |
| BIS | New | PROSHARES TRultsh nasd biot | $2,228,000 | – | 125,000 | +100.0% | 1.46% | – |
| VXX | New | BARCLAYS BK PLCcall | $2,108,000 | – | 50,000 | +100.0% | 1.38% | – |
| AMRI | New | ALBANY MOLECULAR RESH INCcall | $1,859,000 | – | 100,000 | +100.0% | 1.22% | – |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INCcall | $1,788,000 | +137.1% | 200,000 | +100.0% | 1.17% | +111.6% |
| ITMN | New | INTERMUNE INCcall | $1,674,000 | – | 50,000 | +100.0% | 1.10% | – |
| BOTA | Buy | BIOTA PHARMACEUTIALS INC | $1,500,000 | +75.0% | 245,507 | +20.0% | 0.98% | +56.0% |
| SRNE | New | SORRENTO THERAPEUTICS INC | $1,282,000 | – | 100,000 | +100.0% | 0.84% | – |
| TWM | New | PROSHARES TRultsht russ2000 | $1,147,000 | – | 25,000 | +100.0% | 0.75% | – |
| QLTI | New | QLT INCcall | $1,112,000 | – | 200,000 | +100.0% | 0.73% | – |
| PCYC | New | PHARMACYCLICS INCput | $1,002,000 | – | 10,000 | +100.0% | 0.66% | – |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $954,000 | -88.0% | 106,735 | -89.8% | 0.62% | -89.3% |
| BAX | Sell | BAXTER INTL INC | $736,000 | -47.1% | 10,000 | -50.0% | 0.48% | -52.9% |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $682,000 | +73.1% | 103,185 | +24.0% | 0.45% | +54.3% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $582,000 | +2.1% | 150,000 | -25.0% | 0.38% | -8.9% |
| GLMD | New | GALMED PHARMACEUTICALS LTD | $574,000 | – | 50,000 | +100.0% | 0.38% | – |
| ZGNX | New | ZOGENIX INCcall | $569,000 | – | 200,000 | +100.0% | 0.37% | – |
| FCSC | New | FIBROCELL SCIENCE INC | $564,000 | – | 107,769 | +100.0% | 0.37% | – |
| CYTK | CYTOKINETICS INC | $538,000 | +46.2% | 56,666 | 0.0% | 0.35% | +30.4% | |
| CLSN | New | CELSION CORPORATION | $506,000 | – | 150,000 | +100.0% | 0.33% | – |
| FURX | New | FURIEX PHARMACEUTICALS INC | $435,000 | – | 5,000 | +100.0% | 0.28% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $414,000 | -29.6% | 200,000 | -20.0% | 0.27% | -37.1% |
| AMAG | New | AMAG PHARMACEUTICALS INCcall | $387,000 | – | 20,000 | +100.0% | 0.25% | – |
| STML | STEMLINE THERAPEUTICS INC | $335,000 | +3.7% | 16,464 | 0.0% | 0.22% | -7.6% | |
| SNSS | New | SUNESIS PHARMACEUTICALS INCcall | $331,000 | – | 50,000 | +100.0% | 0.22% | – |
| ZGNX | Sell | ZOGENIX INC | $285,000 | -53.0% | 100,000 | -43.3% | 0.19% | -58.2% |
| XNPT | Exit | XENOPORT INC | $0 | – | -77,000 | -100.0% | -0.32% | – |
| CRTX | Exit | CORNERSTONE THERAPEUTICS INCcall | $0 | – | -50,000 | -100.0% | -0.35% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.41% | – |
| CRY | Exit | CRYOLIFE INCcall | $0 | – | -100,000 | -100.0% | -0.81% | – |
| TWM | Exit | PROSHARES TRcall | $0 | – | -100,000 | -100.0% | -0.88% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -58,722 | -100.0% | -1.09% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -45,966 | -100.0% | -1.80% | – |
| GIVN | Exit | GIVEN IMAGINGcall | $0 | – | -100,000 | -100.0% | -2.21% | – |
| ENDP | Exit | ENDO HEALTH SOLUTIONS INCput | $0 | – | -50,000 | -100.0% | -2.48% | – |
| FRX | Exit | FOREST LABS INC | $0 | – | -70,382 | -100.0% | -3.10% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -200,000 | -100.0% | -4.50% | – |
| IBB | Exit | ISHARESput | $0 | – | -75,000 | -100.0% | -12.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.